[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336270-105":59,"doc-detail-336270-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-data-and-future-perspectives-on-dna-methylation-in-ovarian-cancer-review","Current data and future perspectives on DNA methylation in ovarian cancer (Review)","","Ovarian cancer is the most prevalent malignancy of the female reproductive system and is hindered by high aggressiveness, morbidity and mortality, and often lack of apparent symptoms that complicate early detection. Aberrant DNA methylation alters gene expression across many tumor types, and in ovarian cancer it regulates critical genes such as BRCA1/2 and RASSF1A. Promoter methylation can drive tumorigenesis, contribute to medication resistance, and shape patient prognosis. This review discusses how DNA methylation in tumor suppressor genes, oncogenes, signaling pathways, and microRNAs influences disease development and progression, and evaluates advantages and limitations of DNA methylation for diagnosis, treatment, and prevention.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-data-and-future-perspectives-on-dna-methylation-in-ovarian-cancer-review/336270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-data-and-future-perspectives-on-dna-methylation-in-ovarian-cancer-review/336270.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is DNA methylation important in ovarian cancer?","Question",{"text":112,"@type":113},"DNA methylation regulates gene expression by adding methyl groups to DNA promoter regions. In ovarian cancer, it is linked to regulation of critical genes and key epigenetic mechanisms that influence tumor biology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes are highlighted as being regulated by DNA methylation?",{"text":117,"@type":113},"The review highlights methylation-related regulation of BRCA1/2 and Ras-association domain family 1A, including promoter-region methylation that contributes to pathogenesis and clinical outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"How does DNA methylation affect treatment response and prognosis?",{"text":121,"@type":113},"Methylation modifications within promoter regions can contribute to ovarian cancer development and are also associated with medication resistance and differences in patient prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336270,1790740965,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","INTERNATIONAL JOURNAL OF ONCOLOGY 64: 62, 2024  \nCurrent data and future perspectives on DNA methylation in ovarian cancer (Review)  \nMENGYU FU 1* , FENGYING DENG 1* , JIE CHEN 1* , LI FU 1 , JIAHUI LEI 1 , TING XU 1,2 , YOUGUO CHEN 1 , JINHUA ZHOU 1 , QINQIN GAO 1 and HONGMEI DING 1  \n1Institute for Fetology, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China; 2Department of Gynecology and Obstetrics, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215100, P.R. China  \nReceived November 23, 2023; Accepted April 25, 2024  \nDOI: 10.3892/ijo.2024.5650  \nAbstract. Ovarian cancer (OC) represents the most prevalent malignancy of the female reproductive system . Its distin‑ guishing features include a high aggressiveness, substantial morbidity and mortality, and a lack of apparent symptoms, which collectively pose significant challenges for early detec‑ tion. Given that aberrant DNA methylation events leading to altered gene expression are characteristic of numerous tumor types, there has been extensive research into epigenetic mech‑ anisms, particularly DNA methylation, in human cancers . In the context of OC, DNA methylation is often associated with the regulation of critical genes, such as BRCA1/2 and Ras‑association domain family 1A. Methylation modifications within the promoter regions of these genes not only contribute to the pathogenesis of OC, but also induce medication resis‑ tance and influence the prognosis of patients with OC. As such, a more in‑depth understanding of DNA methylation underpinning carcinogenesis could potentially facilitate the development of more effective therapeutic approaches for this intricate disease. The present review focuses on classical tumor suppressor genes, oncogenes, signaling pathways and associated microRNAs in an aim to elucidate the influence of DNA methylation on the development and progression of OC. The advantages and limitations of employing DNA methyla‑ tion in the diagnosis, treatment and prevention of OC are also discussed. On the whole, the present literature review indicates  \nCorrespondence to: Professor Qinqin Gao or Professor Hongmei Ding, Institute for Fetology, Department of Obstetricsand Gynecology, The First Affiliated Hospital of Soochow University, 178 Ganjiang East Road, Pingjiang Street, Gusu, Suzhou, Jiangsu 215006, P.R. China  \nE‑mail: [jennyqgao@126.com](jennyqgao@126.com)  \nE‑mail: [10398836@qq.com](10398836@qq.com)  \n*Contributed equally  \nKey words: DNA methylation, ovarian cancer, tumor suppressor genes, oncogenes, pathways  \nthat the DNA methylation of specific genes could potentially serve as a prognostic biomarker for OC and a therapeutic target for personalized treatment strategies. Further investiga‑ tions in this field may yield more efficacious diagnostic and therapeutic alternatives for patients with OC.  \nContents  \n1. Introduction  \n2. Tumor suppressor genes  \n3. Oncogenes  \n4. Pathways  \n5. MicroRNAs and DNA methylation  \n6. Prospects for the clinical application of DNMT inhibitors in OC  \n7. Conclusion and future perspectives  \n1. Introduction  \nOvarian cancer (OC) is one of the three most prevalent and lethal malignancies affecting the female reproductive organs, alongside endometrial and cervical cancers (1) . Its incidence has been increasing worldwide, and it now has the second highest yearly incidence rate among cancers of the female reproductive system (2,3). Epithelial OC (EOC), which consti‑ tutes 85 to 90% of all ovarian tumors, is the most common subtype (4) . The histological subtypes of EOC vary based on the tissue origin, as detailed in Table I. Malignant ovarian germ cell tumors and sex cord‑stromal tumors, however, are relatively rare (4) . OC is characterized by a combination of direct spread, intraabdominal seeding and lymphatic metas‑ tasis, with peritoneal metastases in the advanced stages of the disease being associated with high m","cbCaivmQE9nwC5sc","https://ap.wps.com/l/cbCaivmQE9nwC5sc","pdf",1377153,"English","# Contents\n## 1. Introduction\n## 2. Tumor suppressor genes\n## 3. Oncogenes\n## 4. Pathways\n## 5. MicroRNAs and DNA methylation\n## 6. Prospects for the clinical application of DNMT inhibitors in OC\n## 7. Conclusion and future perspectives","[{\"question\":\"Why is DNA methylation important in ovarian cancer?\",\"answer\":\"DNA methylation regulates gene expression by adding methyl groups to DNA promoter regions. In ovarian cancer, it is linked to regulation of critical genes and key epigenetic mechanisms that influence tumor biology.\"},{\"question\":\"Which genes are highlighted as being regulated by DNA methylation?\",\"answer\":\"The review highlights methylation-related regulation of BRCA1/2 and Ras-association domain family 1A, including promoter-region methylation that contributes to pathogenesis and clinical outcomes.\"},{\"question\":\"How does DNA methylation affect treatment response and prognosis?\",\"answer\":\"Methylation modifications within promoter regions can contribute to ovarian cancer development and are also associated with medication resistance and differences in patient prognosis.\"}]","Current data and future perspectives on DNA methylation in ovarian cancer (Review) | PDF",1790014318,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5568719329a3975cb6bbceb64a7c47b.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df89bbb60ff621502291922acfa00a78.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3485d555c1329ff7238b5973aadddb8.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c3db535f043f7bd625d7139eaae5131.webp",980,1353]